Your browser doesn't support javascript.
Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19.
Martinelli, Ida; Ciavarella, Alessandro; Abbattista, Maria; Aliberti, Stefano; De Zan, Valentina; Folli, Christian; Panigada, Mauro; Gori, Andrea; Artoni, Andrea; Ierardi, Anna Maria; Carrafiello, Gianpaolo; Monzani, Valter; Grasselli, Giacomo; Blasi, Francesco; Peyvandi, Flora.
  • Martinelli I; A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Via Pace 9, 20122, Milan, Italy. ida.martinelli@policlinico.mi.it.
  • Ciavarella A; A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Via Pace 9, 20122, Milan, Italy.
  • Abbattista M; A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Via Pace 9, 20122, Milan, Italy.
  • Aliberti S; Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
  • De Zan V; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
  • Folli C; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
  • Panigada M; Department of Medicine-Acute Medical Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
  • Gori A; Department of Anesthesia, Intensive Care and Emergency, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
  • Artoni A; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
  • Ierardi AM; Department of Internal Medicine, Infectious Diseases Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
  • Carrafiello G; A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Via Pace 9, 20122, Milan, Italy.
  • Monzani V; Radiology Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
  • Grasselli G; Radiology Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
  • Blasi F; Department of Medicine-Acute Medical Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
  • Peyvandi F; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Intern Emerg Med ; 16(5): 1223-1229, 2021 08.
Article in English | MEDLINE | ID: covidwho-1002167
ABSTRACT
We conducted an observational cohort study in adult patients consecutively admitted for the respiratory illness Covid-19 to our hub hospital from March 9 to April 7, 2020. The high observed rate of venous thromboembolism prompted us to increase the prophylactic doses of enoxaparin from 40 mg daily up to 1 mg/kg twice daily in patients admitted to intensive care units (ICU), 0.7 mg/kg twice daily in high-intensity of care wards and 1 mg/kg daily in low-intensity of care wards. Patients on high enoxaparin doses were compared to those who received prophylaxis with the standard dosage. Efficacy endpoints were mortality, clinical deterioration, and the occurrence of venous thromboembolism, safety endpoint was the occurrence of major bleeding. Of 278 patients with Covid-19, 127 received prophylaxis with high enoxaparin doses and 151 with standard dosage. At 21 days, the incidence rate of death and clinical deterioration were lower in patients on higher doses than in those on the standard dosage (hazard ratio 0.39, 95% confidence interval 0.23-0.62), and the incidence of venous thromboembolism was also lower (hazard ratio 0.52, 95% confidence interval 0.26-1.05). Major bleeding occurred in four of 127 patients (3.1%) on the high enoxaparin dosage. In conclusion, in the cohort of patients with Covid-19 treated with high enoxaparin dosages we observed a 60% reduction of mortality and clinical deterioration and a 50% reduction of venous thromboembolism compared to standard dosage prophylaxis. However, 3% of patients on high enoxaparin dosages had non-fatal major bleeding.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Heparin, Low-Molecular-Weight / Pre-Exposure Prophylaxis / COVID-19 Drug Treatment / Hospitalization Type of study: Cohort study / Observational study / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Intern Emerg Med Journal subject: Emergency Medicine / Internal Medicine Year: 2021 Document Type: Article Affiliation country: S11739-020-02585-9

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Heparin, Low-Molecular-Weight / Pre-Exposure Prophylaxis / COVID-19 Drug Treatment / Hospitalization Type of study: Cohort study / Observational study / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Intern Emerg Med Journal subject: Emergency Medicine / Internal Medicine Year: 2021 Document Type: Article Affiliation country: S11739-020-02585-9